2011 Annual Meeting | Neurodevelopmental Disabilities Across the Lifespan

Date Tuesday 03/19/13

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Max Wiznitzer, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to recognize the clinical features of the discussed NDDs throughout the lifespan; understand their neurobiologic basis and core neuropsychological underpinnings and impact on clinical manifestations; and know the available assessment and intervention options (medication and nonpharmacologic) at various ages for the discussed NDDs and associated comorbid disorders.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Didactic

Event Timeline
01:00 PM - 01:15 PM		Prevalence and Epidemiology of the Neurodevelopmental Disabilities Max Wiznitzer, MD, FAAN
01:15 PM - 02:05 PM		Neurodevelopmental Impact of Prematurity Laura R. Ment, MD
02:05 PM - 03:00 PM		Age Specific Neurodevelopmental Phenotypes of Selected Chromosomal Disorders: What the Neurologist Needs to Know Andrea L. Gropman, MD, FAAN
03:00 PM - 03:15 PM		Break
03:15 PM - 04:05 PM		Autism Spectrum Disorders-Diagnosis and Treatment Deborah Hirtz, MD, FAAN
04:05 PM - 05:00 PM		Use of Complementary and Alternative Medicine in the Neurodevelopmental Disabilities Max Wiznitzer, MD, FAAN

Faculty Disclosures
Deborah Hirtz, MD, FAAN	No disclosure on file
Laura R. Ment, MD	No disclosure on file
Max Wiznitzer, MD, FAAN	Dr. Wiznitzer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Department of Health and Human Services - Vaccine Injury Compensation Program. Dr. Wiznitzer has a non-compensated relationship as a Board of Directors with CHADD that is relevant to AAN interests or activities.
Andrea L. Gropman, MD, FAAN	Dr. Gropman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Change Health Care. Dr. Gropman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cyprium. Dr. Gropman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Gropman has received research support from National Institutes of Health. The institution of Dr. Gropman has received research support from O'Malley Family Foundation.

��ɫ��

��ɫ��